This suggests that CSP‐TTK21, by activating the master epigenetic enzyme p300/CBP, could rescue some of the de‐regulated processes (such as synaptic plasticity and neurodegeneration) associated with AD. Here, DNAJC5 is linked to Alzheimer disease.